161 related articles for article (PubMed ID: 23400406)
41. Alignment-independent 3D-QSAR and molecular docking studies of tacrine-4-oxo-4H-Chromene hybrids as anti-Alzheimer's agents.
Manouchehrizadeh E; Mostoufi A; Tahanpesar E; Fereidoonnezhad M
Comput Biol Chem; 2019 Jun; 80():463-471. PubMed ID: 31170562
[TBL] [Abstract][Full Text] [Related]
42. Alkylated monoterpene indole alkaloid derivatives as potent P-glycoprotein inhibitors in resistant cancer cells.
Cardoso DSP; Kincses A; Nové M; Spengler G; Mulhovo S; Aires-de-Sousa J; Dos Santos DJVA; Ferreira MU
Eur J Med Chem; 2021 Jan; 210():112985. PubMed ID: 33189435
[TBL] [Abstract][Full Text] [Related]
43. Tenulin and isotenulin inhibit P-glycoprotein function and overcome multidrug resistance in cancer cells.
Chang YT; Wang CCN; Wang JY; Lee TE; Cheng YY; Morris-Natschke SL; Lee KH; Hung CC
Phytomedicine; 2019 Feb; 53():252-262. PubMed ID: 30668405
[TBL] [Abstract][Full Text] [Related]
44. Diverse effects of P-glycoprotein inhibitory agents on human leukemia cells expressing the multidrug resistance protein (MRP).
Lehne G; Mørkrid L; den Boer M; Rugstad HE
Int J Clin Pharmacol Ther; 2000 Apr; 38(4):187-95. PubMed ID: 10783828
[TBL] [Abstract][Full Text] [Related]
45. 1,2,3,4-Tetrahydroisoquinoline/2H-chromen-2-one conjugates as nanomolar P-glycoprotein inhibitors: Molecular determinants for affinity and selectivity over multidrug resistance associated protein 1.
Rullo M; Niso M; Pisani L; Carrieri A; Colabufo NA; Cellamare S; Altomare CD
Eur J Med Chem; 2019 Jan; 161():433-444. PubMed ID: 30384046
[TBL] [Abstract][Full Text] [Related]
46. Tetrandrine enhances glucocorticoid receptor translocation possibly via inhibition of P-glycoprotein in daunorubicin-resistant human T lymphoblastoid leukemia cells.
Xu W; Wang X; Chen S; Wu H; Tanaka S; Onda K; Sugiyama K; Yamada H; Hirano T
Eur J Pharmacol; 2020 Aug; 881():173232. PubMed ID: 32525004
[TBL] [Abstract][Full Text] [Related]
47. Discovery of new pyrimidopyrrolizine/indolizine-based derivatives as P-glycoprotein inhibitors: Design, synthesis, cytotoxicity, and MDR reversal activities.
Shawky AM; Abdalla AN; Ibrahim NA; Abourehab MAS; Gouda AM
Eur J Med Chem; 2021 Jun; 218():113403. PubMed ID: 33823396
[TBL] [Abstract][Full Text] [Related]
48. Inhibition of human P-glycoprotein transport and substrate binding using a galantamine dimer.
Namanja HA; Emmert D; Pires MM; Hrycyna CA; Chmielewski J
Biochem Biophys Res Commun; 2009 Oct; 388(4):672-6. PubMed ID: 19683513
[TBL] [Abstract][Full Text] [Related]
49. Effect of Calphostin C (PKC inhibitor) on daunorubicin resistance in P388/ADR and HL60/AR cells: reversal of drug resistance possibly via P-glycoprotein.
Gupta S; Patel K; Singh H; Gollapudi S
Cancer Lett; 1994 Jan; 76(2-3):139-45. PubMed ID: 7511983
[TBL] [Abstract][Full Text] [Related]
50. Quantitative structure-activity relationship and quantitative structure-pharmacokinetics relationship of 1,4-dihydropyridines and pyridines as multidrug resistance modulators.
Zhou XF; Shao Q; Coburn RA; Morris ME
Pharm Res; 2005 Dec; 22(12):1989-96. PubMed ID: 16158213
[TBL] [Abstract][Full Text] [Related]
51. Novel TOPP descriptors in 3D-QSAR analysis of apoptosis inducing 4-aryl-4H-chromenes: comparison versus other 2D- and 3D-descriptors.
Sciabola S; Carosati E; Cucurull-Sanchez L; Baroni M; Mannhold R
Bioorg Med Chem; 2007 Oct; 15(19):6450-62. PubMed ID: 17658263
[TBL] [Abstract][Full Text] [Related]
52. Marine sponge-derived sipholane triterpenoids reverse P-glycoprotein (ABCB1)-mediated multidrug resistance in cancer cells.
Abraham I; Jain S; Wu CP; Khanfar MA; Kuang Y; Dai CL; Shi Z; Chen X; Fu L; Ambudkar SV; El Sayed K; Chen ZS
Biochem Pharmacol; 2010 Nov; 80(10):1497-506. PubMed ID: 20696137
[TBL] [Abstract][Full Text] [Related]
53. A synthetic triptycene bisquinone, which blocks nucleoside transport and induces DNA fragmentation, retains its cytotoxic efficacy in daunorubicin-resistant HL-60 cell lines.
Wang B; Wu M; Perchellet EM; McIlvain CJ; Sperfslage BJ; Huang X; Tamura M; Stephany HA; Hua DH; Perchellet JP
Int J Oncol; 2001 Dec; 19(6):1169-78. PubMed ID: 11713586
[TBL] [Abstract][Full Text] [Related]
54. Multiple drugbinding sites on the R482G isoform of the ABCG2 transporter.
Clark R; Kerr ID; Callaghan R
Br J Pharmacol; 2006 Nov; 149(5):506-15. PubMed ID: 16981002
[TBL] [Abstract][Full Text] [Related]
55. Susceptibility of idarubicin, daunorubicin, and their C-13 alcohol metabolites to transport-mediated multidrug resistance.
Ross DD; Doyle LA; Yang W; Tong Y; Cornblatt B
Biochem Pharmacol; 1995 Nov; 50(10):1673-83. PubMed ID: 7503771
[TBL] [Abstract][Full Text] [Related]
56. Structure-activity relationships of a series of tariquidar analogs as multidrug resistance modulators.
Globisch C; Pajeva IK; Wiese M
Bioorg Med Chem; 2006 Mar; 14(5):1588-98. PubMed ID: 16307883
[TBL] [Abstract][Full Text] [Related]
57. In vitro and in vivo reversal of P-glycoprotein-mediated multidrug resistance by a novel potent modulator, XR9576.
Mistry P; Stewart AJ; Dangerfield W; Okiji S; Liddle C; Bootle D; Plumb JA; Templeton D; Charlton P
Cancer Res; 2001 Jan; 61(2):749-58. PubMed ID: 11212278
[TBL] [Abstract][Full Text] [Related]
58. Understanding polyspecificity within the substrate-binding cavity of the human multidrug resistance P-glycoprotein.
Martinez L; Arnaud O; Henin E; Tao H; Chaptal V; Doshi R; Andrieu T; Dussurgey S; Tod M; Di Pietro A; Zhang Q; Chang G; Falson P
FEBS J; 2014 Feb; 281(3):673-82. PubMed ID: 24219411
[TBL] [Abstract][Full Text] [Related]
59. Studies of the benzopyran class of selective COX-2 inhibitors using 3D-QSAR and molecular docking.
Yadav DK; Saloni ; Sharma P; Misra S; Singh H; Mancera RL; Kim K; Jang C; Kim MH; Pérez-Sánchez H; Choi EH; Kumar S
Arch Pharm Res; 2018 Dec; 41(12):1178-1189. PubMed ID: 28822076
[TBL] [Abstract][Full Text] [Related]
60. A comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA) of anthranilamide derivatives that are multidrug resistance modulators.
Labrie P; Maddaford SP; Fortin S; Rakhit S; Kotra LP; Gaudreault RC
J Med Chem; 2006 Dec; 49(26):7646-60. PubMed ID: 17181148
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
